Reena Mehra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Reena Mehra has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alex Milinovich
Department of Quantitative Health Sciences, Cleveland Clinic , Cleveland, OH
1 shared publicationCatherine M. Heinzinger
Sleep Disorders Center, Cleveland Clinic, Cleveland, Ohio
1 shared publication- Catherine M. Heinzinger
Sleep Disorders Center, Neurological Institute Cleveland Clinic Foundation, Cleveland, USA
1 shared publication Cinthya Pena Orbea
Sleep Disorders Center, Neurological Institute, Cleveland Clinic , Cleveland, OH
1 shared publication- David R. Van Wagoner
Department of Heart, Blood & Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA
1 shared publication - Matheus Araújo
Sleep Disorders Center, Neurological Institute Cleveland Clinic Foundation, Cleveland, USA
1 shared publication
Latest Publications
- 1 July 2025
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 21 (7) , 1149-1150
Influence of sleep architectural disruptions on the evolution of atrial fibrillation
- 1 July 2025
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 21 (7) , 1149-1150
Influence of sleep architectural disruptions on the evolution of atrial fibrillation
- 4 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Polysomnographic sleep architectural disruption associated with atrial fibrillation development
Study Objectives: To examine the unclear, inconsistent role of sleep architectural disruption in atrial fibrillation (AF) development. Methods: Patients (age ≥ 18 years) who underwent in-laboratory sleep studies at Cleveland Clinic 2000–2015 were examined (follow-up: 7.8 ± 3.5 years). Primary predictors were arousal index and total sleep time. Secondary predictors included sleep efficiency, wakefulness after sleep onset, sleep and REM latency, and percentage of each sleep stage. Predictors were fit to Cox proportional hazard models predicting time from sleep study to AF by diagnosis code. Covariates included demographics, anthropometrics, tobacco use, sleepiness, apnea–hypopnea index, sleep apnea-specific hypoxic impact, cardiovascular risk factors and disease, mood disorders, medications, and positive airway pressure. Results: In our cohort (n = 27 232, age: 49.4 ± 14.5 years, 43.7% male, 73.9% white), 2077 (7.6%) developed incident AF. Arousal index was not associated with AF incidence. For every hour of decreased total sleep time, AF incidence increased 8% (HR = 1.08, 95% CI = 1.04 to 1.11). For every 10-unit decrease in sleep efficiency, AF incidence increased 6% (HR = 1.06, 95% CI = 1.04 to 1.09). For every hour of increased wakefulness after sleep onset, AF incidence increased 11% (HR = 1.11, 95% CI = 1.05 to 1.16). For every 10-unit increase in percent N1, AF incidence increased 6% (HR = 1.06, 95% CI = 1.01 to 1.10). Conclusions: Less sleep time and greater sleep disruption were associated with increased incident AF in this large clinical cohort. These results suggest that sleep macro-architecture can influence AF development. Mechanistic and prospective studies are needed to verify whether sleep disruption is a novel target for AF prevention.
- 4 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (6)
Polysomnographic sleep architectural disruption associated with atrial fibrillation development
Study Objectives: To examine the unclear, inconsistent role of sleep architectural disruption in atrial fibrillation (AF) development. Methods: Patients (age ≥ 18 years) who underwent in-laboratory sleep studies at Cleveland Clinic 2000–2015 were examined (follow-up: 7.8 ± 3.5 years). Primary predictors were arousal index and total sleep time. Secondary predictors included sleep efficiency, wakefulness after sleep onset, sleep and REM latency, and percentage of each sleep stage. Predictors were fit to Cox proportional hazard models predicting time from sleep study to AF by diagnosis code. Covariates included demographics, anthropometrics, tobacco use, sleepiness, apnea–hypopnea index, sleep apnea-specific hypoxic impact, cardiovascular risk factors and disease, mood disorders, medications, and positive airway pressure. Results: In our cohort (n = 27 232, age: 49.4 ± 14.5 years, 43.7% male, 73.9% white), 2077 (7.6%) developed incident AF. Arousal index was not associated with AF incidence. For every hour of decreased total sleep time, AF incidence increased 8% (HR = 1.08, 95% CI = 1.04 to 1.11). For every 10-unit decrease in sleep efficiency, AF incidence increased 6% (HR = 1.06, 95% CI = 1.04 to 1.09). For every hour of increased wakefulness after sleep onset, AF incidence increased 11% (HR = 1.11, 95% CI = 1.05 to 1.16). For every 10-unit increase in percent N1, AF incidence increased 6% (HR = 1.06, 95% CI = 1.01 to 1.10). Conclusions: Less sleep time and greater sleep disruption were associated with increased incident AF in this large clinical cohort. These results suggest that sleep macro-architecture can influence AF development. Mechanistic and prospective studies are needed to verify whether sleep disruption is a novel target for AF prevention.